Oncology

Squamous cell carcinoma of the penis

ORPHA:398058 ↗

Search all Squamous cell carcinoma of the penis trialsAlert me when a trial opens

studies recruiting now

as of 7 Sept 2026

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

9 Apr 2026

most recent study posted

among recruiting studies

Recruiting trials

RecruitingPhase 2NCT03866382

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Sponsor National Cancer Institute (NCI)Where United States, Puerto Rico (581 sites)Studying Biospecimen Collection, Bone ScanUpdated 4 Sept 2026

See details

RecruitingPhase 1NCT07217171

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Sponsor EvolveImmune United, IncWhere United States (15 sites)Studying EVOLVE104, EVOLVE104Updated 28 Aug 2026

See details

RecruitingPhase 2NCT06161532

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Sponsor National Cancer Institute (NCI)Where United States (1 site)Studying Sacituzumab govitecan, AtezolizumabUpdated 13 Aug 2026

See details

RecruitingPhase 2NCT07518979

EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer

Sponsor Jiyan LiuWhere China (1 site)Studying Becotatug Vedotin, PucotenlimabUpdated 29 Jul 2026

See details

RecruitingPhase 2NCT07110038

DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma

Sponsor Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestWhere Germany (8 sites)Studying Avelumab, enfortumab vedotinUpdated 22 Jun 2026

See details

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 14 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

China Germany Puerto Rico United States

Keep watching

Get an email when a new Squamous cell carcinoma of the penis study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:398058 ↗

About Squamous cell carcinoma of the penis

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Treatments being studied

2 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 2Cabozantinib

Phase 2Pembrolizumab (Keytruda)

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).